Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes.

ABSTRACT:

Aim

To investigate potential cost savings associated with the use of real-time continuous glucose monitoring (RT-CGM) throughout pregnancy in women with Type 1 diabetes.

Methods

A budget impact model was developed to estimate, from the perspective of National Health Service England, the total costs of managing pregnancy and delivery in women with Type 1 diabetes using self-monitoring of blood glucose (SMBG) with and without RT-CGM. It was assumed that the entire modelled cohort (n = 1441) would use RT-CGM from 10 to 38 weeks' gestation (7 months). Data on pregnancy and neonatal complication rates and related costs were derived from published literature, national tariffs, and device manufacturers.

Results

The cost of glucose monitoring was £588 with SMBG alone and £182

SUBMITTER: Murphy HR 

PROVIDER: S-EPMC6900078 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature